Search results for " Fatty liver"

showing 8 items of 338 documents

MBOAT7 locus rs641738 variant predisposes to hepatocellular carcinoma in nonalcoholic fatty liver

2016

nonalcoholic fatty liver diseaseHepatologyHepatocellular carcinomabusiness.industrySettore MED/12 - GASTROENTEROLOGIAFatty liverGastroenterologyLocus (genetics)medicine.diseaseHepatocellular carcinoma; nonalcoholic fatty liver disease03 medical and health sciences0302 clinical medicineN/A030220 oncology & carcinogenesisHepatocellular carcinomaNonalcoholic fatty liver diseasemedicineCancer research030211 gastroenterology & hepatologybusinessDigestive and Liver Disease
researchProduct

Differences between current clinical guidelines for screening, diagnosis and management of non-alcoholic fatty liver disease and real-world practice:…

2021

International audience; INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease and is associated with obesity and metabolic comorbidities. Liver steatosis can progress to nonalcoholic steatohepatitis (NASH) exhibiting a relevant risk of fibrosis and ultimately liver failure. To date, no approved treatment for NASH to reduce its clinical and humanistic burden has been developed. AREAS COVERED: We undertook a literature review to identify English language, national and international clinical guidelines for NAFLD regarding diagnosis, assessment and management, and determined their points of agreement and difference. Additionally, we investigated published liter…

nonalcoholic fatty liver diseaseNonalcoholic steatohepatitismedicine.medical_specialtyliterature review[SDV]Life Sciences [q-bio]Liver fibrosisdigestive systemGastroenterologyDiagnosis DifferentialLiver diseasereal-world practiceLiver steatosisNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseasemedicineHumansMass Screeningnonalcoholic steatohepatitisliver fibrosisHepatologybusiness.industryGastroenterologynutritional and metabolic diseasesfood and beveragesmedicine.diseaseObesitydigestive system diseases[SDV] Life Sciences [q-bio]clinical guidelinesPractice Guidelines as Topicbusiness
researchProduct

The rs2294918 E434K variant modulates PNPLA3 expression and liver damage.

2015

The PNPLA3 rs738409 polymorphism (I148M) is a major determinant of hepatic fat and predisposes to the full spectrum of liver damage in nonalcoholic fatty liver disease (NAFLD). Aim of this study was to evaluate whether additional PNPLA3 coding variants contribute to NAFLD susceptibility, first in individuals with contrasting phenotypes (with early onset NAFLD vs. very low aminotransferases), and then in a large validation cohort. Rare PNPLA3 variants were not detected by sequencing coding regions and intron-exon boundaries either in 142 patients with early-onset NAFLD, nor in 100 healthy individuals with ALT A polymorphism (E434K sequence variant) was over-represented in NAFLD (adjusted p=0…

nonalcoholic fatty liver diseaselipid dropletgenetichepatic fat contentnonalcoholic steatohepatitis
researchProduct

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient …

2021

Purpose: This study prospectively assessed the performance of liver stiffness measurements using point shear-wave elastography (p-SWE) in comparison with transient elastography (TE) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD). Methods: Fifty-six consecutive adult patients with a histological diagnosis of NAFLD prospectively underwent TE and p-SWE on the same day. The median of 10 measurements (SWE-10), the first five (SWE-5), and the first three (SWE-3) measurements were analyzed for p-SWE. Liver biopsy was considered as the reference standard for liver fibrosis grade. Receiver operating characteristic (ROC) curves and areas under the ROC curves (AUROCs) were cal…

nonalcoholic fatty liver diseasemedicine.medical_specialtyGastroenterologySettore MED/01 - Statistica Medica030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineLiver stiffnessInternal medicineStatistical significanceBiopsyNonalcoholic fatty liver diseaseMedical technologymedicineRadiology Nuclear Medicine and imagingnonalcoholic steatohepatitisR855-855.5shear wave elastographymedicine.diagnostic_testReceiver operating characteristicbusiness.industryNonalcoholic fatty liver disease Nonalcoholic steatohepatitis Shear wave elastography Transient elastography Liver stiffnessmedicine.diseasetransient elastographyliver stiffnessLiver biopsyOriginal Article030211 gastroenterology & hepatologyElastographySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessTransient elastographyUltrasonography
researchProduct

IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION

2019

Background: Background:Nonalcoholic fatty liver (NAFL) is a major cause of liver disease worldwide leading also to a higher risk of cardiovascular events. We aimed to evaluate the impact of fatty liver and fibrosis on cardiovascular risk factors in a general population. Methods: 604 subjects included in the community-based ABCD (Alimentazione, Benessere Cardiovascolare e Diabete) study were recruited. Steatosis (CAP >288 dB/m) and fibrosis (> 8.7 KPa by M and > 7.2 KPa by XL probe) were assessed with FibroScan Cardiovascular risk was evaluated by the Atherosclerotic Cardiovascular Disease (ASCVD) risk estimator and de ned low if <5%, borderline if 5%-7 4%, intermediate if 7-9% a…

obesity diabetes steatosis ABCD study fatty liver disease
researchProduct

MAFLD vs NAFLD: Let the contest begin!

2020

obesityHepatologybusiness.industrysteatosiMEDLINEmedicine.diseaseBioinformaticsCONTESTObesityArticle03 medical and health sciences0302 clinical medicineInsulin resistanceNon-alcoholic Fatty Liver Disease030220 oncology & carcinogenesismedicinefatty liver diseaseHumans030211 gastroenterology & hepatologySteatosisInsulin ResistancebusinessHumanLiver International
researchProduct

Correlation of Metabolic Syndrome with Redox Homeostasis Biomarkers: Evidence from High-Fat Diet Model in Wistar Rats

2022

Metabolic Syndrome (MetS) is an extremely complex disease. A non-balanced diet such as high-fat diet (HFD) induces metabolic dysfunction that could modify redox homeostasis. We here aimed at exploring redox homeostasis in male Wistar rats, following 8 weeks of HFD, correlating the eventual modification of selected biomarkers that could be associated with the clinical manifestations of MetS. Therefore, we selected parameters relative to both the glucose tolerance and lipid altered metabolism, but also oxidative pattern. We assessed some biomarkers of oxidative stress i.e., thiols balance, lipid peroxidation and antioxidant barriers, via the use of specific biochemical assays, individuating e…

oxidative streglucose toleranceSettore BIO/16 - Anatomia UmanaPhysiologyClinical Biochemistrynon-alcoholic fatty liver diseaseCell BiologySettore BIO/09 - FisiologiaBiochemistryoxidative stress; anti-oxidant barriers; glucose tolerance; lipid metabolism; non-alcoholic fatty liver disease; adipose tissue distributionanti-oxidant barrierlipid metabolismMolecular Biologyadipose tissue distributionAntioxidants
researchProduct

The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity

2015

white matter lesions Non-alcoholic Fatty Liver DiseaseSettore MED/09 - Medicina InternaSettore MED/37 - NeuroradiologiaSettore MED/26 - NeurologiaSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct